Outgoing superintendent runs last Shikellamy school board meeting
Bendle officially announced his resignation from the district on June 5 and agreed to remain the district's leader until Aug. 5 when he takes over as superintendent of Berwick Area School District.
Bendle previously said he will miss the district and working with the administration, teachers, staff and school board.
'I am proud of the work that was accomplished together here at Shikellamy,' he said. 'I wish the district nothing but the best moving forward.'
The Berwick Area School District board of directors held a special meeting in June, hiring Bendle by an 8-1 count and giving him a five-year contract.
Bendle still had more than two years remaining on his Shikellamy contract.
Bendle was hired by Shikellamy in 2019 following his departure from Danville.
Shikellamy board President Wendy Wiest thanked Bendle for his service to the district.
'I would like to personally thank Dr. Bendle for his fiscal responsibility, vision, leadership and professionalism to put Shikellamy in a strong financial and educational position,' she said. 'I wish him much success in his next endeavor.'
Bendle touted the district's financial situation and said he was proud the district did not raise taxes in the past three years.
'It has been a privilege to lead this district and I will never forget the accomplishments we did together,' Bendle said.
Shikellamy continues to search for a new superintendent while also waiting for at least three new school directors to join the board after the general election.
The November ballot will feature five candidates for four open seats.
Political newcomers Tara Sprenkel and Chris Bucher and incumbent Jenna Eister-Whitaker all won dual nominations. Political newcomer Dennis Deitrich won in the Republican primary. Community activist Victoria Rosancrans won in the Democratic primary, but withdrew from the race. The Northumberland County Democratic Party is interviewing potential candidates to fill Rosancrans' spot on the ballot.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Mandelson's plea to Blair for a fresh chance
Peter Mandelson's desperation to get back into government after twice being forced to resign from Tony Blair's cabinet is revealed in newly-released official files. According to papers released by the National Archives in Kew, west London, Mr Mandelson (as he then was) even enlisted the help of former BBC director general Lord Birt in his campaign to secure another top job. His efforts were rewarded when Mr Blair appointed him to the plum post of Britain's commissioner on the European Commission in Brussels with responsibility for trade. Mr Mandelson was forced to quit as Northern Ireland secretary in January 2001 following claims he had helped the controversial Indian businessman Srichand Hinduja secure a UK passport in return for sponsoring the Millennium Dome. Although an official inquiry cleared him of any impropriety, Mr Blair was reluctant to bring his old friend back into the fold after he had already resigned once before in a scandal over an undeclared home loan from fellow Labour minister Geoffrey Robinson. In April 2003, however, Lord Birt – who was serving as a senior policy adviser in No 10 – wrote to the prime minister urging him to think again. 'I gather from Peter that you still talk to him regularly – but, as a safeguard, you may like to know what he reports to me about his current state of mind,' he wrote. 'He feels this spring/summer may be the moment of decision for him. He's approaching 50 – and he is sorely conscious that time is passing and he has yet to fulfil his promise. 'As you know, Peter's deepest wish is to return to government. He stresses that he has already proved to be a capable minister, and that he would be a strong ally for you in cabinet. 'If you judge a return to government is not possible, then he would like you to consider appointing him as EC Commissioner. 'One way or another, he says he wants to settle his future this year, even if it means a career outside politics.' Just four months later, it was announced that he was to be the UK's next European commissioner. He was subsequently awarded a life peerage in 2008 and is currently the British Ambassador to the United States.
New York Times
2 hours ago
- New York Times
Former NFLPA executive director Lloyd Howell Jr. resigns from The Carlyle Group
Former NFL Players Association executive director Lloyd Howell Jr. resigned from his role at The Carlyle Group, a spokesperson confirmed to The Athletic on Monday. The spokesperson did not give details as to when or why Howell resigned. ESPN first reported the news. On Thursday, Howell resigned from his role with the NFLPA amid rising criticism over the union's leadership and concerns about a potential conflict of interest involving Howell and his involvement with The Carlyle Group. Advertisement As reported by ESPN on July 10, Howell worked as a paid, part-time consultant to The Carlyle Group since March 2023, three months before he was elected NFLPA executive director. He stayed in the role even after the NFL approved private equity minority investors, including The Carlyle Group, in August 2024. Two sources with knowledge of the NFLPA's hiring process told The Athletic that union leadership was aware of Howell's work with the firm during the hiring process. One year later, when the firm had the opportunity to invest in the NFL, four sources with knowledge of the situation said discussions about Howell's role occurred and lawyers for the NFLPA and The Carlyle Group decided Howell's work in the aerospace and defense division was distant enough from the group's work with the NFL. An NFLPA source with knowledge of the situation disputed details in the ESPN report, which stated that an NFLPA attorney had requested that Howell consider resigning from his role with The Carlyle Group while still serving as executive director of the NFLPA. Three other sources said they had not heard of an NFLPA lawyer making that request to Howell. Reporting from ESPN, Pro Football Talk and 'Pablo Torre Finds Out' uncovered layers of dysfunction within union leadership within the past month, including findings that the NFLPA reached a confidentiality agreement with the NFL to hide information about an arbitration decision involving potential collusion over guaranteed contracts. In a statement announcing his resignation from the NFLPA, Howell said: 'It's clear that my leadership has become a distraction to the important work the NFLPA advances every day.' JC Tretter, former NFLPA chief strategy officer and a frontrunner to take over as interim executive director, resigned from the organization on Sunday. In an interview published by CBS, Tretter said he did not want to be considered for the interim job, nor be a part of the NFLPA. A source briefed on the procedure said the NFLPA executive board still plans to meet in the coming days to determine a process for selecting an interim executive director.
Yahoo
3 hours ago
- Yahoo
Sharp Therapeutics Corp. Announces Results from Annual Meeting of Shareholders
Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - Sharp Therapeutics Corp. (TSXV: SHRX) ("Sharp" or the "Company"), a pre-clinical biotechnology company developing small molecule therapies to treat genetic diseases, is pleased to announce the voting results from its annual general meeting of shareholders held on July 18, 2024 (the "Meeting"). All nominees set forth in the Company's management information circular dated June 10, 2025 (the "Circular") were elected as directors of the Company at the Meeting. Detailed results of the votes are set out below: Nominee Number of Shares Percentage of Votes For Withheld For Withheld Scott Sneddon 10,923,102 0 100 % 0% William R. Newlin 10,923,102 0 100 % 0% John L. Brooks III 10,923,102 0 100 % 0% Dietrich Stephan 10,923,102 0 100 % 0% John Hathaway 10,923,102 0 100 % 0% Lorne Sugarman 10,923,102 0 100 % 0% The Circular also sought approval to re-appoint MNP LLP as auditors of the Company and to authorize the board of directors of the Company to fix the auditors' remuneration. The results of the shareholder votes for this item is set out below: Motion Number of Shares For Percentage of Votes For Appointment of Auditors 10,923,102 100 % About Sharp Therapeutics Corp. First-Choice Therapies for Genetic Diseases Sharp Therapeutics is a pre-clinical stage company developing first-choice small-molecule therapeutics for genetic diseases. The Company's discovery platform combines novel high throughput screening technologies, with compound libraries computational optimized based on the physics and biology of cellular trafficking defects and allosteric activation of proteins. The platform produces small molecule compounds that restore activity in mutated proteins giving the potential to treat genetic disorders with conventional pill-based medicines. For additional information on Sharp, please visit: Contacts:Scott Sneddon, PhD, JDChief Executive Officer412-206-5303 or scott@ Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. To view the source version of this press release, please visit
